Human Genetic Editing: Analysis of Some Ethical Challenges

Journal: Advances in Medicine and Engineering Interdisciplinary Research DOI: 10.32629/ameir.v2i3.2430

Sofía P. Salas

Bioethics Center, Faculty of Medicine, Clínica Alemana Universidad del Desarrollo

Abstract

Scientific advances suggest that, in the near future, the possibility of editing the genes of a new individual, either by acting on germ cells or in preimplantation embryos, will be within the reach of the entire population, a possibility that raises important ethical concerns. At the end of 2018, the international scientific community expressed its concern about the experiments carried out by Dr. He Jiankui who, through the CRISPR-Cas 9 technique, genetically modified human embryos for reproductive purposes, achieving the birth of at least two girls. In this article, we will make an ethical analysis of Dr. Jiankui's experiment following Emanuel's criteria; according to this view, this experiment did not comply with any of the ethical standards commonly used by research ethics committees when evaluating a protocol. We will then review the ethical controversies related to the use of human gene editing in germ cells (sperms and eggs) and preimplantation embryos for reproductive purposes. Considering that these changes are heritable for future generations, and that the technique is still in an experimental stage, we will argue in favor of a moratorium on its use for these purposes. When gene editing is used without reproductive purposes but solely for research, we will justify why we consider it necessary to distinguish the application of this technique in germ cells from research in human embryos, a distinction that may be questioned depending on whether the human embryo is considered as a living organism of the human species. Likewise, we will briefly discuss the differences that exist between the use of genetic editing techniques to cure or prevent diseases, and that used to produce improvements or "enhancement" of the human race, since the latter has several moral objections. We will end with a brief analysis of regulatory aspects in Chile and internationally, since some of the applications of these techniques raise ethical issues that have highlighted the need for strong supervision in this area.

Keywords

gene editing; CRISPR-Cas system; ethics; genetic enhancement; research

References

[1] Pérez-Triviño JL. Bioética y cine: Gattaca. Rev Bioét Der. 2009;15:15-8. Disponible en: http://www.ub.edu/fildt/revista/ pdf/RByD15_Cine.pdf
[2] Beca JP, Lecaros A, González P, Sanhueza P, Mandakovic B. Aspectos médicos, éticos y legales de la criopreservación de embriones humanos [Medical, ethical and legal issues in cryopreservation of human embryos]. Rev Med Chil. 2014;142(7):903-8. Spanish. doi: 10.4067/S0034-98872014000700011
[3] WHO Expert Advisory Committee on Developing Global Standards for Governance and Oversight of Human Genome Editing. Human Genome Editing: A Framework for Governance. Geneva: World Health Organization; 2021. Disponible en: https://www.who.int/publications/i/item/9789240030060
[4] Gupta RK, Abdul-Jawad S, McCoy LE, Mok HP, Peppa D, Salgado M, et al. HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation. Nature. 2019;568(7751):244-248. doi: 10.1038/s41586-019-1027-4
[5] Emanuel EJ, Wendler D, Grady C. What makes clinical research ethical? JAMA. 2000;283(20):2701-11. doi:10.1001/jama.283.20.2701
[6] Cyranoski D. The CRISPR-baby scandal: what's next for human gene-editing. Nature. 2019;566(7745):440-442. doi: 10.1038/d41586-019-00673-1
[7] Zhou M, Greenhill S, Huang S, Silva TK, Sano Y, Wu S, et al. CCR5 is a suppressor for cortical plasticity and hippocampal learning and memory. Elife. 2016;5:e20985. doi: 10.7554/eLife.20985
[8] Adikusuma F, Piltz S, Corbett MA, Turvey M, McColl SR, Helbig KJ, et al. Large deletions induced by Cas9 cleavage. Nature. 2018;560(7717):E8-E9. doi: 10.1038/s41586-018-0380-z
[9] Krimsky S. Ten ways in which He Jiankui violated ethics. Nat Biotechnol. 2019;37(1):19-20. doi: 10.1038/nbt.4337
[10] Hurlbut JB. Human genome editing: ask whether, not how. Nature. 2019;565(7738):135. doi: 10.1038/d41586-018-07881-1
[11] Rehmann-Sutter C. Why human germline editing is more problematic than selecting between embryos: Ethically considering intergenerational relationships. New Bioeth. 2018;24(1):9-25. doi: 10.1080/20502877.2018.1441669
[12] Battisti D. Affecting future individuals: Why and when germline genome editing entails a greater moral obligation towards progeny. Bioethics. 2021;35(5):487-495. doi: 10.1111/bioe.12871
[13] Buller T, Bauer S. Balancing procreative autonomy and parental responsibility. Camb Q Healthc Ethics. 2011;20(2):268-76. doi: 10.1017/S0963180110000915
[14] Chung SH, Sin TN, Ngo T, Yiu G. CRISPR Technology for Ocular Angiogenesis. Front Genome Ed. 2020;2:594984. doi: 10.3389/fgeed.2020.594984
[15] Rossidis AC, Stratigis JD, Chadwick AC, Hartman HA, Ahn NJ, Li H, et al. In utero CRISPR-mediated therapeutic editing of metabolic genes. Nat Med. 2018;24(10):1513-1518. doi: 10.1038/s41591- 018-0184-6
[16] Savulescu J. In defence of Procreative Beneficence. J Med Ethics. 2007;33(5):284-8. doi: 10.1136/jme.2006.018184
[17] Savulescu J. Procreative beneficence: why we should select the best children. Bioethics. 2001;15(5-6):413-26. doi: 10.1111/1467-8519.00251
[18] Sandel M. The Case Against Perfection: Ethics in the Age of Genetic Engineering. Cambrige: Harvard University Press. 2007.
[19] Habermas J. The Future of Human Nature. Cambridge, UK: Polity Press. 2003.
[20] National Academies of Sciences, Engineering, and Medicine; National Academy of Medicine; National Academy of Sciences; Committee on Human Gene Editing: Scientific, Medical, and Ethical Considerations. Human Genome Editing: Science, Ethics, and Governance. Chapter 8. Washington (DC): National Academies Press (US); 2017. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK447280/
[21] BCN. Biblioteca del congreso Nacional de Chile. Ley 20.120. Sobre la Investigación Científica en el Ser Humano, su Genoma, y Prohibe la Clonación Humana. 2006. Disponible en: https://www.bcn.cl/ leychile/navegar?idNorma=253478
[22] Lander ES, Baylis F, Zhang F, Charpentier E, Berg P, Bourgain C, et al. Adopt a moratorium on heritable genome editing. Nature. 2019;567(7747):165-168. doi: 10.1038/d41586-019- 00726-5
[23] Wolinetz CD, Collins FS. NIH supports call for moratorium on clinical uses of germline gene editing. Nature. 2019;567(7747):175. doi: 10.1038/d41586-019-00814-6
[24] Baylis F, Darnovsky M, Hasson K, Krahn TM. Human Germ Line and Heritable Genome Editing: The Global Policy Landscape. CRISPR J. 2020;3(5):365-377. doi: 10.1089/crispr.2020.0082

Copyright © 2024 Sofía P. Salas

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License